UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update

Archivos de bronconeumología (English ed.), 2015-04, Vol.51 (4), p.185-192

2015

Volltextzugriff (PDF)

Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial

Trials, 2020-07, Vol.21 (1), p.632-3, Article 632

2020

Volltextzugriff (PDF)

Factors associated with the evolution of lung function in patients with alpha-1 antitrypsin deficiency in the Spanish registry

Archivos de bronconeumología (English ed.), 2011-10, Vol.47 (10), p.495-503

2011

Volltextzugriff (PDF)

miR-320c Regulates SERPINA1 Expression and Is Induced in Patients With Pulmonary Disease

Archivos de bronconeumología, 2021-07, Vol.57 (7), p.457-463

2021

Volltextzugriff (PDF)

Severe COVID-19 Illness and α1-Antitrypsin Deficiency: COVID-AATD Study

Biomedicines, 2023-02, Vol.11 (2), p.516

2023

Volltextzugriff (PDF)

Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency: Database Evaluation and Population Analysis

Archivos de bronconeumología (English ed.), 2017-01, Vol.53 (1), p.13-18

2017

Volltextzugriff (PDF)

Varenicline in smokers with severe or very severe COPD after 24 weeks of treatment. A descriptive analysis: VALUE study

Monaldi archives for chest disease, 2017-12, Vol.87 (3), p.874-874

2017

Volltextzugriff (PDF)

Intercostal Neuropathy and Pain Due to Pleuritis

Pain medicine (Malden, Mass.), 2013-05, Vol.14 (5), p.769-770

2013

Volltextzugriff (PDF)

Usefulness of the CAT, LCOPD, EQ-5D and COPDSS Scales in Understanding the Impact of Lung Disease in Patients with Alpha-1 Antitrypsin Deficiency

Chronic obstructive pulmonary disease, 2014-09, Vol.11 (5), p.480-488

2014

Volltextzugriff (PDF)

Do Smokers Who Only Attend the First Appointment of a Smoking Cessation Consultation Have Distinguishing Characteristics?

Archivos de bronconeumología (English ed.), 2023-10, Vol.59 (10), p.678-680

2023

Volltextzugriff (PDF)

Is the motivation to quit smoking greater if the smoker is going to quit smoking of their own free will or when advised by a health professional?

Tobacco induced diseases, 2022-05, Vol.20 (May), p.47-3

2022

Volltextzugriff (PDF)

Fagerström Test and Heaviness Smoking Index. Are they Interchangeable as a Dependence Test for Nicotine?

Substance use & misuse, 2020-01, Vol.55 (2), p.200-208

2020

Volltextzugriff (PDF)

Sputum Microbiome Dynamics in Chronic Obstructive Pulmonary Disease Patients during an Exacerbation Event and Post-Stabilization

Respiration, 2019-11, Vol.98 (5), p.447-454

2019

Volltextzugriff (PDF)

Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin

International journal of chronic obstructive pulmonary disease, 2023-01, Vol.18, p.1691-1700

2023

Volltextzugriff (PDF)

Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry

The European respiratory journal, 2023-03, Vol.61 (3), p.2201949

2023

Volltextzugriff (PDF)

Intensive dietary advice program in primary care

Enfermeria clinica, 2012-09, Vol.22 (5), p.269

2012

Volltextzugriff (PDF)

Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency: Database Evaluation and Population Analysis

Archivos de bronconeumología (English ed.), 2017-01, Vol.53 (1), p.13-18

2017

Volltextzugriff (PDF)

miR-320c Regulates SERPINA1 Expression and Is Induced in Patients With Pulmonary Disease

Archivos de bronconeumología (English ed.), 2021-07, Vol.57 (7), p.457-463

2021

Volltextzugriff (PDF)

Registro español de pacientes con déficit de alfa-1 antitripsina: evaluación de la base de datos y análisis de la población incluida

Archivos de bronconeumología, 2017-01, Vol.53 (1), p.13-18

2017

Volltextzugriff (PDF)

Actualización sobre indicaciones de búsqueda activa de casos y tratamiento con alfa-1 antitripsina por vía intravenosa en pacientes con enfermedad pulmonar obstructiva crónica asociada a déficit de alfa-1 antitripsina

Archivos de bronconeumología, 2015-04, Vol.51 (4), p.185-192

2015

Volltextzugriff (PDF)

Relación entre la autoeficacia para dejar de fumar, la voluntad propia y quién envía a los pacientes

Revista de patología respiratoria, 2023-01, Vol.25 (4)

2023

Volltextzugriff (PDF)

Existe asociación entre el grado de dependencia por la nicotina y la motivación para dejar de fumar?

Archivos de bronconeumología, 2019-03, Vol.55 (3), p.139-145

2019

Volltextzugriff (PDF)

Is the motivation to quit smoking a predictor of abstinence maintenance?

Tobacco prevention & cessation, 2021-06, Vol.7 (June), p.1-13

2021

Volltextzugriff (PDF)

When Should We Measure Self-Efficacy as an Aid to Smoking Cessation?

Archivos de bronconeumología (English ed.), 2019-12, Vol.55 (12), p.654-656

2019

Volltextzugriff (PDF)

En qué momento deberíamos medir la autoeficacia para ayudar a dejar de fumar?

Archivos de bronconeumología, 2019-12, Vol.55 (12), p.654-656

2019

Volltextzugriff (PDF)

1 – 25 von 232

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(199)
Mit Volltextzugriff
(204)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update

Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial

Factors associated with the evolution of lung function in patients with alpha-1 antitrypsin deficiency in the Spanish registry

miR-320c Regulates SERPINA1 Expression and Is Induced in Patients With Pulmonary Disease

Severe COVID-19 Illness and α1-Antitrypsin Deficiency: COVID-AATD Study

Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency: Database Evaluation and Population Analysis

Varenicline in smokers with severe or very severe COPD after 24 weeks of treatment. A descriptive analysis: VALUE study

Intercostal Neuropathy and Pain Due to Pleuritis

Usefulness of the CAT, LCOPD, EQ-5D and COPDSS Scales in Understanding the Impact of Lung Disease in Patients with Alpha-1 Antitrypsin Deficiency

Do Smokers Who Only Attend the First Appointment of a Smoking Cessation Consultation Have Distinguishing Characteristics?

Is the motivation to quit smoking greater if the smoker is going to quit smoking of their own free will or when advised by a health professional?

Fagerström Test and Heaviness Smoking Index. Are they Interchangeable as a Dependence Test for Nicotine?

Sputum Microbiome Dynamics in Chronic Obstructive Pulmonary Disease Patients during an Exacerbation Event and Post-Stabilization

Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin

Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry

Intensive dietary advice program in primary care

Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency: Database Evaluation and Population Analysis

miR-320c Regulates SERPINA1 Expression and Is Induced in Patients With Pulmonary Disease

Registro español de pacientes con déficit de alfa-1 antitripsina: evaluación de la base de datos y análisis de la población incluida

Actualización sobre indicaciones de búsqueda activa de casos y tratamiento con alfa-1 antitripsina por vía intravenosa en pacientes con enfermedad pulmonar obstructiva crónica asociada a déficit de alfa-1 antitripsina

Relación entre la autoeficacia para dejar de fumar, la voluntad propia y quién envía a los pacientes

Existe asociación entre el grado de dependencia por la nicotina y la motivación para dejar de fumar?

Is the motivation to quit smoking a predictor of abstinence maintenance?

When Should We Measure Self-Efficacy as an Aid to Smoking Cessation?

En qué momento deberíamos medir la autoeficacia para ayudar a dejar de fumar?

Suchergebnisse filtern